<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36964314</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Increasing prevalence 2015-2019 of amyotrophic lateral sclerosis in Sardinia, Italy.</ArticleTitle><Pagination><StartPage>2781</StartPage><EndPage>2786</EndPage><MedlinePgn>2781-2786</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-023-06753-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While amyotrophic lateral sclerosis (ALS) incidence has increased during the last decades, structured evidence on increased prevalence is lacking. After reporting a significant yearly increase of ALS incidence over a 10-year period, we checked for increased prevalence in Southern Sardinia over a quinquennium.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">ALS patients (El Escorial Criteria) recruited from the study area and followed at ALS Centre, University of Cagliari, were included. Prevalence was computed for January 1, 2015 and January 1, 2019 and was calculated for the overall ALS population as well as for tracheostomized and non-tracheostomized patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed a non-significant trend for greater ALS prevalence in 2019 than in 2015 (18.31 per 100,000 vs. 15.26 per 100,000; rate ratio: 1.83, p&#x2009;=&#x2009;0.01). By contrast, a significantly raising 2015 to 2019 ALS prevalence was observed in tracheostomized patients. No significant difference could be detected in non-tracheostomized.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We provided the highest prevalence rate to date reported in the worldwide literature, and also showed a non-significant raising ALS prevalence in the Sardinian population over a quinquennium. The trend in raising ALS prevalence was likely due to extended survival due to invasive interventions.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Pateri</LastName><ForeName>Maria Ida</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pilotto</LastName><ForeName>Silvy</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7950-0136</Identifier><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy. pilottosilvy@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy. pilottosilvy@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borghero</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pili</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierri</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ercoli</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gigante</LastName><ForeName>Angelo Fabio</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Section of Neurology, San Paolo Hospital, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muroni</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defazio</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amyotrophic Lateral Sclerosis Centre, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Sardinia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36964314</ArticleId><ArticleId IdType="pmc">PMC10345082</ArticleId><ArticleId IdType="doi">10.1007/s10072-023-06753-5</ArticleId><ArticleId IdType="pii">10.1007/s10072-023-06753-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Belbasis L, Bellou V, Evangelou E. Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiology. 2016;46:96&#x2013;105. doi: 10.1159/000443146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443146</ArticleId><ArticleId IdType="pubmed">26731747</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CA, Lally C, Kupelian V, Flanders WD. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants. Neuroepidemiology. 2021;55(5):342&#x2013;353. doi: 10.1159/000516752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000516752</ArticleId><ArticleId IdType="pubmed">34247168</ArticleId></ArticleIdList></Reference><Reference><Citation>Puopolo M, Bacigalupo I, Piscopo P, et al. Latium Registry Group, Vanacore N. Prevalence of amyotrophic lateral sclerosis in Latium region, Italy. Brain Behav. 2021;11(12):e2378. doi: 10.1002/brb3.2378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2378</ArticleId><ArticleId IdType="pmc">PMC8671775</ArticleId><ArticleId IdType="pubmed">34716673</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg R, FarrugiaWismayer M, et al. Genetic analysis of ALS cases in the isolated island population of Malta. Eur J Hum Genet. 2021;29(4):604&#x2013;614. doi: 10.1038/s41431-020-00767-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-020-00767-9</ArticleId><ArticleId IdType="pmc">PMC8115635</ArticleId><ArticleId IdType="pubmed">33414559</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu T, Liu L, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020;267(4):944&#x2013;953. doi: 10.1007/s00415-019-09652-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, Ilardi A, Bertuzzo D, Bersano E, Cugnasco P, Grassano M, Pisano F, Mazzini L, Calvo A, Piemonte and Valle d&#x2019;Aosta Register for ALS (PARALS) Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d'Aosta Register. JAMA Neurol. 2017;74(9):1097&#x2013;1104. doi: 10.1001/jamaneurol.2017.1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugliatti M, Parish LD, Cossu P, et al. Amyotrophic lateral sclerosis in Sardinia, insularItaly, 1995&#x2013;2009. J Neurol. 2013;260(2):572&#x2013;579. doi: 10.1007/s00415-012-6681-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6681-5</ArticleId><ArticleId IdType="pubmed">23052600</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G, Pierri V, Vasta R, et al. Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age-sex interaction and spatial-temporal variability. Amyotroph Lateral Scler Frontotemporal Degener. 2022;21:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35188026</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G, Pugliatti M, Marrosu F, et al. Genetic architecture of ALS in Sardinia. Neurobiol Aging. 2014;35:2882. doi: 10.1016/j.neurobiolaging.2014.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.012</ArticleId><ArticleId IdType="pmc">PMC4252367</ArticleId><ArticleId IdType="pubmed">25123918</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Palese F, Sartori A, Verriello L, et al. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002&#x2013;2014: a retrospective population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(1&#x2013;2):90&#x2013;99. doi: 10.1080/21678421.2018.1511732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1511732</ArticleId><ArticleId IdType="pubmed">30430867</ArticleId></ArticleIdList></Reference><Reference><Citation>Scial&#xf2; C, Novi G, Bandettini di Poggio M, et al. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: an update of LIGALS register. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(7&#x2013;8):535&#x2013;542. doi: 10.1080/21678421.2016.1197942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1197942</ArticleId><ArticleId IdType="pubmed">27399231</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugliatti M, Parish LD, Cossu P, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995&#x2013;2009. J Neurol. 2013;260(2):572&#x2013;579. doi: 10.1007/s00415-012-6681-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6681-5</ArticleId><ArticleId IdType="pubmed">23052600</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R, Moglia C, Manera U, et al. What is amyotrophic lateral sclerosis prevalence? Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:203&#x2013;208. doi: 10.1080/21678421.2021.1936557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1936557</ArticleId><ArticleId IdType="pubmed">34151660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetin H, Rath J, F&#xfc;zi J, et al. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course. Neuroepidemiology. 2015;44(1):6&#x2013;15. doi: 10.1159/000369813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369813</ArticleId><ArticleId IdType="pubmed">25571962</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et al. Respiratory support in a population-based ALS cohort: demographic, timing and survival determinants. J Neurol Neurosurg Psychiatry. 2022;93(9):1024&#x2013;1026. doi: 10.1136/jnnp-2021-327968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327968</ArticleId><ArticleId IdType="pmc">PMC9380473</ArticleId><ArticleId IdType="pubmed">35817551</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>